TIDMCTEC

RNS Number : 3391L

ConvaTec Group PLC

12 May 2022

ConvaTec Group Plc

Results of Annual General Meeting

Reading, United Kingdom (12 May 2022) - Poll Result

ConvaTec Group Plc ("ConvaTec") held its Annual General Meeting today ("AGM"). The results of the poll held in relation to the resolutions proposed at the AGM are set out below

 
                     For (see note                  Against (see                         Votes           % of          Votes 
                      2)                             note 2)                              Total           ISC          Witheld 
                                                                                                         Voted 
 Resolution          No of shares         %                No of          % 
                                                           Shares 
                    -------------------  --------  --------------------  -------                                ------------------- 
      Receive 
      Annual 
      Report 
 1    and Accounts        1,827,980,026   99.99%               138,955    0.01%         1,828,118,981   89.85%           2,678,250 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Approve 
      the 
      Directors' 
      Remuneration 
 2    Report              1,310,074,242   72.51%          496,566,511     27.49%        1,806,640,753   88.80%         24,156,478 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Declare 
      Final 
 3    Dividend            1,828,471,889   99.87%             2,318,530    0.13%         1,830,790,419   89.98%                6,812 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Re-elect 
      John McAdam 
      as a 
 4    director            1,785,547,176   97.61%            43,742,972    2.39%         1,829,290,148   89.91%           1,507,083 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Re-elect 
      Karim Bitar 
      as a 
 5    director            1,824,546,868   99.66%             6,234,317    0.34%         1,830,781,185   89.98%              16,046 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Re-elect 
      Margaret 
      Ewing 
 6    director            1,808,325,168   98.77%            22,443,302    1.23%         1,830,768,470   89.98%              28,761 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Re-elect 
      Brian May 
      as a 
 7    director            1,713,823,773   94.03%          108,742,705     5.97%         1,822,566,478   89.58%           8,230,753 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Re-elect 
      Sten 
      Scheibye 
      as a 
 8    director            1,824,824,180   99.68%             5,944,289    0.32%         1,830,768,469   89.98%              28,762 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Re-elect 
       Heather 
       Mason as 
 9     a director         1,812,618,794   99.01%            18,149,676    0.99%         1,830,768,470   89.98%              28,761 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Re-elect 
      Professor 
      Constantin 
      Coussios 
      as a 
 10   director            1,811,236,685   98.93%            19,521,954    1.07%         1,830,758,639   89.98%              38,592 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Elect Jonny 
       Mason as 
 11    a director         1,819,579,146   99.39%            11,187,969    0.61%         1,830,767,115   89.98%              30,116 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Elect Kim 
       Lody as 
 12    a director         1,824,822,794   99.68%             5,812,573    0.32%         1,830,635,367   89.98%             161,864 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Elect Sharon 
      O'Keefe 
      as a 
 13   director            1,824,954,544   99.68%             5,812,573    0.32%         1,830,767,117   89.98%              30,114 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Re-appoint 
      Deloitte 
      LLP as 
 14   auditors            1,828,465,498   99.95%               830,907    0.05%         1,829,296,405   89.91%           1,500,826 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Authorise 
      the 
      Directors 
      to agree 
      the 
      auditors' 
 15   remuneration        1,830,098,448   99.96%               671,868    0.04%         1,830,770,316   89.98%              26,915 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Authorise 
      political 
      donations 
      and 
      political 
 16   expenditure         1,814,389,000   99.12%            16,165,069    0.88%         1,830,554,069   89.97%             241,662 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Authorise 
       allotment 
 17    of shares          1,737,684,352   94.92%            93,082,507    5.08%         1,830,766,859   89.98%              30,372 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Renew the 
      Scrip 
      Dividend 
 18   Scheme.             1,830,739,805   100.00%                22,649   0.00%         1,830,762,454   89.98%              34,777 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Disapply 
       pre-emption 
 19    rights*            1,796,085,428   98.35%            30,153,440    1.65%         1,826,238,868   89.76%           4,558,363 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Disapply 
      pre-emption 
      rights in 
      connection 
      with an 
      acquisition 
      or specified 
      capital 
 20   investment*         1,773,062,102   97.09%            53,175,701    2.91%         1,826,237,803   89.76%           4,559,428 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Authorise 
      purchase 
      of own 
 21   shares*             1,828,587,725   99.91%             1,634,548    0.09%         1,830,222,273   89.96%             574,958 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
      Call general 
       meetings 
       on 14 days' 
 22    notice*            1,726,127,643   94.28%          104,652,489     5.72%         1,830,780,132   89.98%              17,099 
     -------------  -------------------  --------  --------------------  -------  -------------------  -------  ------------------- 
 

*Special Resolution

NOTES:

   1.   All resolutions were passed. 
   2.   Votes "For" and "Against" are expressed as a percentage of votes received. 

3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

4. Total number of shares in issue at close of business on 10 May 2022 was 2,034,572,935 shares. 89.88% of capital was voted.

   5.   Computershare acted as scrutineer of the poll on all resolutions. 

In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business that were passed at the annual general meeting have been submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

AGM - Resolution Two

The Board notes the voting result in relation to Resolution 2 at today's Annual General Meeting. We are grateful for the feedback and indications of support received from shareholders in advance of the Meeting and will continue to engage with shareholders who were unable to support this resolution, in order to understand their views in advance of publishing an update statement within six months of today. The Board also plans to engage with shareholders later in the year on the Remuneration Policy which will be subject to approval at the 2023 AGM.

Board Changes

As previously announced, Dr Regina Benjamin did not stand for re-election at the AGM. Sharon O'Keefe has been appointed as ConvaTec's designated Non-Executive Director for workforce engagement with effect from 13 May 2022. This statement is made in accordance with Listing Rule 9.6.11.

Enquiries

Analysts and Investors

   Kate Postans, Vice President, Investor Relations                        +44 (0)7826 447 807 

ir@convatec.com

Media

   Buchanan: Charles Ryland / Chris Lane                                       +44 (0)207 466 5000 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

# # #

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGUUAVRUBUVAAR

(END) Dow Jones Newswires

May 12, 2022 11:25 ET (15:25 GMT)

Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Giu 2022 a Lug 2022 Clicca qui per i Grafici di Convatec
Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Lug 2021 a Lug 2022 Clicca qui per i Grafici di Convatec